MBI registers 13% rise in Q3 revenues

摘要

US biological crop protection business Marrone Bio Innovations (MBI – Davis, California) clocked a 12.5% increase in revenues to $9.9 million for its third fiscal quarter ended September 30th 2021. The company notes that its “strategic focus” on global expansion in major row crops aided performance, adding that its distribution partners acquired seed treatments in advance for the 2022 growing season. Furthermore, sales of biological fungicides improved during the period, despite drought conditions affecting the US specialty crops market.